Abstract:Objective: To research the clinical effect and safety of high dose somatostatin, omeprazole combined with hemostasis on the acute upper gastrointestinal bleeding patients combined with coagulation dysfunction. Methods: 92 patients of acute upper gastrointestinal bleeding patients combined with coagulation dysfunction from January 2014 to December 2017. According to random number table method, thoes patients were divided into control group and research group, control group was treated with conventional dose somatostatin and omeprazole combined with hemostasis, and the research group was treated with high doses of somatostatin, and the remaining omeprazole and hemostasis were used the same as control group. After treatment, then clinical efficacy, hemostasis and hospitalization time, blood routine index, coagulation function before and after treatment, and complications between two group was compared. Results: After treatment, total effective rate in research group was obvious higher than control group (91.30％ vs 74.42％) (P＜0.05). While the average hemostatic time, rehemostasis rate and hospitalization time in research group were lesser than the control group (P＜0.05). White blood cells (WBC), partial activation thrombin time (APTT) and prothrombin time (PT) were decreased than before treatment, hemoglobin (Hb), erythrocyte count (RBC), hematocrit (Hct) and platelet count (PLT) in both group were increased than before treatment, while the changes of the above indicators in the research group were more significant than those in the control group (P＜0.05). Complication rate between the two groups was no statistically significant difference (P＞0.05). Conclusion: Clinical effect of high dose somatostatin, omeprazole combined with hemostasis on the acute upper gastrointestinal bleeding patients combined with coagulation dysfunction is better than conventional dose somatostatin and omeprazole combined with hemostasis, can shorten the bleeding time, to avoid rebleeding, and did not increase the adverse drug reactions, high safety.

Effects of salvia miltiorrhiza injection on coagulation function of decompensated liver cirrhosis

Effects of YMB Injection on Hemorheology in Rats

[Clinical Study on Treatment of Cirrhosis by Different Dosages of Salvia Injection].

[Effects of Autologous Peripheral Stem Cell Transplantation on Acoustic Radiation Force Impulse in Patients with HBV-related Decompensated Cirrhosis].

Effect of salvia miltiorrhiza injection on inflammatory indicators of type 2 diabetes patients with lower extremity vascular disease

Treatment with Salvia Miltiorrhiza Prolongs the Survival of Rats with Severe Acute Pancreatitis

Effects of Astragalus injection and Salvia Miltiorrhiza injection on serum inflammatory markers in patients with stable coronary heart disease: a randomized controlled trial study

Myocardial Protection by Salvia miltiorrhiza Injection in Streptozotocin-induced Diabetic Rats through Attenuation of Expression of Thrombospondin-1 and Transforming Growth Factor-beta 1

The study of effects of combination of puerarin and compound salvia miltiorrhiza on thrombogenic and fibrinolytic activities in patients with unstable angina pectoris

Effects of Salvia Miltiorrhiza Injection on Nonalcoholic Steatohepatitis and Lipid Metabolism in the Rats Induced by Fat-Rich Diet

[Influence of Safflower Injection on Hemorheology of Patients of Chronic Cor Pulmonale During Acute Attack].

The Influence of Shenmai Injection on the Anticoagulation of Warfarin and Inflammatory Response in Patients Undergoing Cardiac Valve Replacement

Effects of Astragalus injection and Salvia Miltiorrhiza injection on serum inflammatory markers in patients with stable coronary heart disease: a randomized controlled trial protocol

Effect of Shengmai Injection on Cardiac Function and Inflammatory Reaction in Patients with Acute Coronary Syndrome

A clinical study of alprostadil vs salvia miltiorrhiza in treatment of 115 patients with cerebral infarction

Effect of Salvia Miltiorrhiza Bunge Injection on Anticardiolipin Antibody Production Induced by Beta2 Glycoprotein.

Salvia miltiorrhiza stem‐leaf active components of salvianolic acids and flavonoids improved the hemorheological disorder and vascular endothelial function on microcirculation dysfunction rats

[Preventive effects of Salvia miltiorrhiza on multiple organ edema in the rats of limb ischemia/reperfusion]

Clinical Effect of High Dose Somatostatin, Omeprazole Combined with Hemostasis on the Acute Upper Gastrointestinal Bleeding Patients combined with Coagulation Dysfunction

The Effection of Shenfu Injection (Ginseng-Radix Aconitum Injection) to the Coagulation in the Patient of Multiple Trauma Complicated with Shock

The effect of Salvia Miltiorrhiza injection on biomechanical index during repairing process after skeletal muscle contusion of rats